Cosciens Biopharma INC. (CSCIF) — 20-F Filings

All 20-F filings from Cosciens Biopharma INC.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.

20-F Filings (2)

COSCIENS Biopharma Files 20-F, Details 2024 Financials — Apr 9, 2025 Risk: medium
COSCIENS Biopharma Inc. filed its 20-F report for the fiscal year ending December 31, 2024. The company, formerly known as Aeterna Zentaris Inc., is in the phar
Aeterna Zentaris Inc. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — Mar 27, 2024 Risk: low
Aeterna Zentaris Inc. (CSCIF) filed a Foreign Annual Report (20-F) with the SEC on March 27, 2024. Aeterna Zentaris Inc. filed its 20-F annual report on March 2

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX